Integrity Alliance LLC. Increases Stock Position in The Clorox Company $CLX

Integrity Alliance LLC. lifted its holdings in The Clorox Company (NYSE:CLX) by 359.8% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 8,759 shares of the company’s stock after purchasing an additional 6,854 shares during the period. Integrity Alliance LLC.’s holdings in Clorox were worth $883,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of CLX. Center for Financial Planning Inc. purchased a new stake in shares of Clorox in the 3rd quarter worth approximately $25,000. Vermillion & White Wealth Management Group LLC purchased a new stake in Clorox during the third quarter valued at approximately $25,000. Darwin Wealth Management LLC purchased a new stake in Clorox during the second quarter valued at approximately $29,000. Vision Financial Markets LLC increased its stake in Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock valued at $32,000 after purchasing an additional 200 shares in the last quarter. Finally, Ameriflex Group Inc. increased its stake in Clorox by 1,436.8% during the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock valued at $36,000 after purchasing an additional 273 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

CLX opened at $96.19 on Friday. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03. The company has a market cap of $11.63 billion, a price-to-earnings ratio of 15.62, a PEG ratio of 0.50 and a beta of 0.59. The Clorox Company has a 52-week low of $84.70 and a 52-week high of $132.03. The firm’s fifty day simple moving average is $98.82 and its two-hundred day simple moving average is $105.92.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue was up .1% compared to the same quarter last year. During the same period last year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have issued reports on CLX shares. TD Cowen upped their price target on shares of Clorox from $98.00 to $111.00 and gave the company a “hold” rating in a research note on Tuesday, March 31st. Wells Fargo & Company cut their price objective on shares of Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research note on Monday, May 18th. Royal Bank Of Canada cut their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research note on Thursday, April 9th. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. One research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $103.40.

Insider Transactions at Clorox

In related news, Director Pierre R. Breber acquired 5,000 shares of the firm’s stock in a transaction on Tuesday, May 5th. The shares were acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the completion of the acquisition, the director directly owned 18,000 shares in the company, valued at approximately $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.63% of the stock is currently owned by insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.